Recursion Pharmaceuticals
upcoming potential milestones near term medium term potential option exercises for partnership programs potential option exercises for map building initiatives or data sharing multiple for discovered programs interim safety analysis expected top line data expected potential for additional partnership in large intractable potential for additional and clinical starts areas of biology and or technological innovation clinical trial for difficile colitis program expected potential for additional and clinical starts including trial initiation for program potential for consolidation of technologies talent and assets to accelerate the recursion potential option exercises for partnership programs potential option exercises for map building initiatives or data sharing potential additional partnership in large intractable areas of biology and or technological innovation recursion moves towards autonomous map building and navigation with digital and micro synthetic chemistry strong in cash and cash equivalents at the end of with potential for increased revenue in the near term | Recursion Pharmaceuticals
Deck Type
Deck date
January 2023
Slide
140 of 143
Related slides by other companies
Investor Presentation
August 2023
Investor Presentation
May 2023
Investor Day
December 2021
Investor Presentation
February 2024
Search Thousands of Presentations by World Leading Companies